In­di­an drug­mak­er seeks to toss 'bloat­ed' bil­lion-dol­lar law­suit over Covid vac­cine can­di­date

A drug man­u­fac­tur­er is look­ing to end a suit brought on by a Seat­tle-based biotech.

Em­cure Phar­ma­ceu­ti­cals, a Pune, In­dia-based man­u­fac­tur­er of gener­ic drugs, is press­ing a court in Wash­ing­ton to toss out a suit brought on by HDT Bio over a vac­cine to pre­vent Covid-19.

The cur­rent mo­tion filed by Em­cure on Fri­day seeks to dis­miss the case on sev­er­al grounds, par­tial­ly be­cause the court has no au­thor­i­ty over an In­di­an com­pa­ny, Em­cure says, and be­cause there is no way that Em­cure could dam­age HDT.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER